A rapid screening system evaluates novel inhibitors of DNA methylation and suggests F-box proteins as potential therapeutic targets for high-risk neuroblastoma.

Saved in:

Bibliographic Details
Title:	A rapid screening system evaluates novel inhibitors of DNA methylation and suggests F-box proteins as potential therapeutic targets for high-risk neuroblastoma.
Authors:	Penter L; Labor für Pädiatrische Molekularbiologie, Charité - Universitätsmedizin Berlin, 10117, Berlin, Germany. livius.penter@charite.de., Maier B; Institut für Medizinische Immunologie, AG Chronobiologie, Charité - Universitätsmedizin Berlin, 10115, Berlin, Germany., Frede U; Labor für Pädiatrische Molekularbiologie, Charité - Universitätsmedizin Berlin, 10117, Berlin, Germany., Hackner B; CIPSM, Fakultät für Chemie und Pharmazie, Ludwig-Maximilians-Universität, 81377, München, Germany., Carell T; CIPSM, Fakultät für Chemie und Pharmazie, Ludwig-Maximilians-Universität, 81377, München, Germany., Hagemeier C; Labor für Pädiatrische Molekularbiologie, Charité - Universitätsmedizin Berlin, 10117, Berlin, Germany., Truss M; Labor für Pädiatrische Molekularbiologie, Charité - Universitätsmedizin Berlin, 10117, Berlin, Germany. matthias.truss@charite.de.
Source:	Targeted oncology [Target Oncol] 2015 Dec; Vol. 10 (4), pp. 523-33. Date of Electronic Publication: 2015 Jan 06.
Publication Type:	Journal Article
Journal Info:	Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1776-260X
DOI:	10.1007/s11523-014-0354-5